Fritextsökning
Innehållstyper
-
Changeable proteins cause nerve disease
An incorrectly folded protein is one of the reasons behind the nerve disease ALS, according to new research. But the protein does not have structural errors all...
-
From planning stage to handshake
"Partnering is an effective tool to get in touch with the decision makers high up in an organization's administration," says Camilla Huse Bondeson at Conlega. A...
-
Google ger sig in i biotech-branschen
Sökmotorjättens nystartade bolag Calico ska fokusera på åldrande och åldersrelaterade sjukdomar.
-
Prenatal testing breakthrough
For the first time specific gene expression information from fetal cells isolated from maternal blood samples is available.
-
Vuxna med inflammatorisk tarmsjukdom har ökad dödlighet
Personer som insjuknar i inflammatorisk tarmsjukdom i vuxen ålder löper en ökad risk att dö i förtid, men sett över tid har dödligheten minskat. Det visar studi...
-
Extra långa oligonukleotider
Oligosyntetisering. Syntetisering av långa oligonukleotider har hittills varit svår att utföra i stor skala.
-
Cate Poulsen, Qiagen
Why are you going to Scanlab and Biotech Forum?
-
Grant for development projects in Gothenburg
Seven research projects receive SEK 1 million to promote commercialization of early drug development and medical technology.
-
Teams up with leading dermatologist
Tripep has signed a letter of intent with a major Japanese specialty pharma company to bring their wound healing treatment to a big market.
-
Academy for a new turn at work
Are you qualified within life science, but unemployed? Here is your chance for a new career, in high demand.
-
Jönköpings cancerpatienter lever längst
Sämst chans att överleva cancer efter fem år har patienterna i Gävleborg. Bäst har de som bor i Jönköping.
-
Blottning i automatiserat system
iBlot Dry Blotting System från Invitrogen används tilsammans med engångskassetter och fungerar helt utan separata buffertar för att blotta proteiner på 7 minuter.
-
New member to Active board
The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be ...
-
Så här fördelas Vetenskapsrådets pengar
3,5 miljarder kronor till forskningen, varav 1,2 miljarder till medicin och hälsa – det är facit när Vetenskapsrådet tagit beslut om majoriteten av årets utlysningar.
-
Swedish top scientists to EMBO
Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and on...
-
Positivt bemötande för Recipharm
Läkemedelstillverkarens aktie klev in på Stockholmsbörsen med ett glädjeskutt i samband med att bolaget noterades i dag.
-
Researchers goes to the bottom of the brain
Swedish researchers have recently got new and deeper knowledge about the smallest part of the brain, the granule cells.
-
How to get visitors to your booth
Food, ball throwing and laser engraved pens. There are many tricks to attract visitors to the stands at Scanlab.
-
Welcome to wonderful Copenhagen
Strategically located, the Danish capital is the focal point of one of the most dynamic regions in Northern Europe. Here are some tips on where to spend your ti...
-
Fat cells' reaction differs with body weight
The fat cells of overweight people may react differently to dietary changes than in their lean peers, according to a pioneering study from the Dutch organizatio...
-
Major changes to the Q-Med board
The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.
-
Crafoord Prize to an American and two Japanese
Today the Royal Swedish Academy of Sciences announces the laureates of the Crafoord Prize in Polyarthritis 2009.
-
We are poor lobbyists
I doubt there has ever been a really well thought out Scandinavian campaign with intentions to really change attitudes among both the public and politicians.
-
An industry emerging from crisis
"Scanlab is normally indicative of the status of investment incentives in the laboratory industry "